Journal of Endocrinology and Metabolism

Coen D.A. Stehouwer, MD, PhD, FESC
Professor and Chair, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands Read more...
Herbert Herzog
, PhD
Adjunct Professor, Faculty of Medicine, The University of New South Wales, Sydney, Australia

ISSN-print: 1923-2861  |  ISSN-online: 1923-287X  |  Bimonthly  | Open Access  | Aims and Scope

Indexed and covered by: Scopus, Chemical Abstract (CA); EBSCO; Worldcat; Google Scholar; PubMed: selected citations only (NIH supported articles); Clarivate Analytics Emerging Sources Citation Index (ESCI-Web of Science)

Scopus CiteScore 2020: 0.7, Rank 176/219 (19th Percentile)

Journal archiving and digital preservation:


  • Epicardial Adipose Tissue Thickness as a Reliable Marker of Increased Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus

    Epicardial adipose tissue (EAT) is a distinct visceral adipose tissue that is present in between the visceral pericardium and myocardium, in which the coronary arteries are lodged. This tissue releases several inflammatory and atherogenic mediators which lead to the initiation and/or progression of coronary atherosclerosis ...

  • Association of Diabetes and Severe COVID-19 Outcomes: A Rapid Review and Meta-Analysis

    Addressing the urgent need for evidence on diabetes as a serious comorbidity for severe illness and death from coronavirus disease 2019 (COVID-19), we investigated the association between diabetes and COVID-19 disease severity in patients hospitalized due to COVID-19.

  • Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Hepatic Fibrosis in Patients With Type 2 Diabetes: A Chart-Based Analysis

    The presence of nonalcoholic fatty liver diseases (NAFLDs) and type 2 diabetes was associated with elevated risks of cardiovascular events as well as the progression of NAFLD to fibrosis/cirrhosis and hepatocellular carcinoma.

  • Effects of Policosanol in Patients With Metabolic Syndrome: A Six-Month Study

    The metabolic syndrome comprises a set of cardiovascular risk factors represented by obesity of central distribution, dyslipidemias, glucose metabolism abnormalities and arterial hypertension, closely associated with insulin resistance. The aim of this study is to investigate in the medium term the effects of policosanol in patients with metabolic syndrome, as well as its safety and tolerability.

  • Acute Pancreatitis in a Patient With Parathyroid Carcinoma

    Parathyroid carcinoma is a rare endocrine malignancy. Clinical features of parathyroid carcinoma are mainly due to the effects of primary hyperparathyroidism (PHPT). Hypercalcemia produced by primary or secondary hyperparathyroidism is a rare and unclear cause of acute pancreatitis.







Treating Obesity: Lifestyle, New Options in Pharmacotherapy, and the Obesogenic Environment
Obesity is a chronic disease of pandemic proportions. Obesity reduces life expectancy, because it is associated with hypertension, dyslipidemia, type 2 diabetes, cardiovascular disease, and certain types of cancer. Additionally, it is associated with a severe course of coronavirus disease 2019 (COVID-19), although it is unclear to what extent that association is causal. Full Text

Correlation Between Changes in the Serum Magnesium Concentration and Visceral Fat Volume in Patients With Type 2 Diabetes Receiving Luseogliflozin: A Sub-Analysis of Data From the LIGHT Study
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors have been reported to more effectively suppress cardiovascular events (CVEs) in patients with type 2 diabetes. The underlying mechanism, however, remains unknown. Full Text

Image of the Issue


An Unusual Complication of Cabergoline Treatment of Macroprolactinomas
Dopamine agonist (DA) treatment is the first choice treatment of prolactinomas. Optic chiasm prolapse with secondary visual deterioration is an unusual and rare complication of DA treatment. A 40-year-old man with giant prolactinoma was successfully treated by cabergoline. After 14 months, he presented with a visual impairment with no ophthalmologic anomalies that could explain this worsening. Full Text

Current Issue


Vol. 11, No. 2, Apr 2021

Table of Contents


Treating Obesity: Lifestyle, New Options in Pharmacotherapy, and the Obesogenic Environment Abstract HTML PDF
Coen D.A. Stehouwer 33-34

Original Article

Correlation Between Changes in the Serum Magnesium Concentration and Visceral Fat Volume in Patients With Type 2 Diabetes Receiving Luseogliflozin: A Sub-Analysis of Data From the LIGHT Study Abstract HTML PDF
Tatsuo Yanagawa, Hideshi Matsuda, Masahiro Sugawara, Masahiro Fukuda, Takashi Sasaki 35-41
The Significance of Insulin Resistance in Nondiabetic Breast Cancer Patients Abstract HTML PDF
Berrin Papila Kundaktepe, Sinem Durmus, Mahir Cengiz, Fatih Orkun Kundaktepe, Volkan Sozer, Cigdem Papila, Remise Gelisgen, Hafize Uzun 42-48

Case Report

Is There Any Association Between Diabetes and Intussusception in Adults? A Case Report Abstract HTML PDF
Arshad Mahmood, Mohamed H. Ahmed, Khalid Canna 49-51
An Unusual Complication of Cabergoline Treatment of Macroprolactinomas Abstract HTML PDF
Amal Moumen, Sanae Chakdoufi, Hamza El Jadi, Ouijdane Zammani, Cherif Abad El Asri, Ghizlaine Belmejdoub 52-55
Clinical Variability of Hypophosphatasia in Colombian Patients: Case Reports Abstract HTML PDF
Ana Maria Zarante Bahamon, Juan Carlos Prieto Rivera, Jorge Rojas, Vladimir Gonzalez Lopez, Victor Vargas, Melissa Rosero Arevalo 56-64

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website:   editorial contact:
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.